About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT00616317

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Lead sponsor: University of California, Davis•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Lavjay Butani

CONTACT

Sponsors

Lead Sponsor

University of California, Davis

Collaborators

Ministry of Higher Education, Science and Technology, Solvenia

Age

0 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•18 years of age or younger at the onset of disease
•Presence of Vascular Thrombosis
•UC Davis patient
•Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma

Exclusion Criteria

•Infants born to mothers with APS
•Infants with congenital thrombophilia

Related studies

Rheumatology Patient Registry and Biorepository

NCT04402086 · Rheumatic Diseases, Adult Onset Still Disease, and more

Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

NCT07372170 · Antiphospholipid Syndrome (APS), Venous Thrombosis (Disorder), and more

Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome

NCT06373926 · Antiphospholipid Syndrome

RECRUITINGPhase 1/2

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

NCT06828042 · Systemic Lupus Erthematosus, Systemic Sclerosis (SSc), and more

RECRUITINGPhase 1

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

NCT06978647 · Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 5, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment50

Start dateSep 2006

Last updatedDec 5, 2025

Condition

Antiphospholipid Syndrome

Locations shown

UC Davis Medical Center

Sacramento, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 5, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions